分娩期乳头刺激疗法用于引产:一项关于可接受性与可行性的随机对照外部预试验
这项单中心平行组随机对照外部预试验评估了分娩期乳头刺激疗法与缩宫素引产对比的大规模随机对照试验是否可行且可被患者和产科医护人员接受。研究纳入≥36周计划使用外源性缩宫素引产的孕妇,按产次分层以3:1随机分配至乳头刺激组或立即缩宫素组,主要结局为招募、方案依从性、随访及交叉率。共24例入组(乳头刺激组18例,缩宫素组6例),交叉率为1/24(4%),作者认为随机分配至任一组均可行且可接受。
要点
- 24例孕妇入组,乳头刺激组18例、缩宫素组6例,交叉率为1/24(4%)。
- 17例执行乳头刺激者中位刺激时长198分钟(四分位距125-291分钟)。
- 乳头刺激组17例中15例(88%)分娩前 later 接受了缩宫素输注。
核心结论
- 随机分配至分娩期乳头刺激疗法或缩宫素输注用于引产是可行的,且可被患者和产科医护人员接受。
研究设计与样本
- 单中心平行组随机对照外部预试验(ClinicalTrials.gov标识NCT04756089),纳入≥36周计划接受外源性缩宫素引产的孕妇,排除<18岁、非英语使用者或胎儿新生儿重症监护风险增加者,按产次分层以3:1随机分配至分娩期乳头刺激疗法或立即接受缩宫素。
主要发现
- 2021年3月13日至2021年6月23日共620例孕妇接受引产,557例潜在合格者中53例被可用的研究人员接触,53例中24例(45%)同意并入组:18例随机至乳头刺激组,6例随机至缩宫素组。
- 乳头刺激组1例因临床照护延迟而退出并接受缩宫素(交叉率1/24[4%]),缩宫素组1例因 spontaneous 产程进展未接受缩宫素,其余所有参与者遵循分配干预。
- 17例执行乳头刺激者中位刺激时长198分钟(四分位距125-291分钟),达到10分钟窗口内至少3次宫缩(平均>30分钟,即「充分」宫缩)所需中位刺激时间为69分钟(四分位距21-80分钟)。
- 乳头刺激组17例中15例(88%)分娩前 later 接受了缩宫素输注;从干预开始至分娩的中位时间乳头刺激组为16.4小时(四分位距0.6-28.2小时),缩宫素组为20.6小时(四分位距14.2-23.4小时)。
- 12例(50%)完成了产后研究问卷。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nipple stimulation is purported as a natural and inexpensive method for inducing labor, but its use is understudied. OBJECTIVE: We aimed to assess whether conducting a large randomized controlled trial comparing intrapartum nipple stimulation therapy with oxytocin infusion is feasible and acceptable to patients and obstetrical care providers. STUDY DESIGN: This single-center parallel-group randomized controlled external pilot study (ClinicalTrials.gov Identifier NCT04756089) included women at ≥36 weeks of gestation who were planned to receive exogenous oxytocin for their labor induction. Women who were <18 years old, non-English speaking, or with fetuses at increased risk of neonatal intensive care were excluded. Stratified by parity, women were randomized 3:1 to intrapartum nipple stimulation therapy or immediate receipt of oxytocin. Women assigned to nipple stimulation therapy were asked to stimulate with an electric breast pump or by hand for periods of at least 30 minutes, with breaks as needed for up to 15 minutes at a time, for at least a cumulative 2 hours before considering initiation of oxytocin, and to complete intrapartum diaries. Labor characteristics and outcomes were examined. Validated questionnaires were used to assess the participants' pain level during the intervention, their sense of control during childbirth, and their breastfeeding success. Primary outcome measures were recruitment, adherence to study protocol and follow-up, and crossover rates. RESULTS: A total of 620 women underwent labor induction from March 13, 2021 to June 23, 2021. Of 557 potentially eligible women, 53 were approached by available research staff. Of the 53 women, 24 (45%) consented and enrolled: 18 randomized to nipple stimulation and 6 randomized to oxytocin. Moreover, 1 woman assigned to nipple stimulation withdrew because of delay of clinical care and received oxytocin (crossover rate of 1/24 [4%]), and 1 woman assigned to oxytocin did not receive it because of spontaneous labor progress. All other participants followed their assigned intervention. The 17 women who performed nipple stimulation stimulated for a median duration of 198 (interquartile range, 125-291) minutes and required a median of 69 (interquartile range, 21-80) minutes of stimulation before achieving at least 3 contractions in a 10-minute window, averaged >30 minutes (also known as "adequate" contractions). Among those assigned to nipple stimulation therapy, 15 of 17 women (88%) later received oxytocin infusion before delivery. The median times from intervention start to delivery were 16.4 (interquartile range, 0.6-28.2) hours for women assigned to nipple stimulation and 20.6 (interquartile range, 14.2-23.4) hours for women assigned to oxytocin infusion. Of note, 12 women (50%) completed their postpartum study questionnaires. CONCLUSION: Random assignment to either intrapartum nipple stimulation therapy or oxytocin infusion for labor induction was feasible and acceptable to patients and obstetrical care providers.
引用
- Stark EL, Athens ZG, Son M, et al. Intrapartum nipple stimulation therapy for labor induction: a randomized controlled external pilot study of acceptability and feasibility. Am J Obstet Gynecol MFM. 2022. PMID: 35042047. doi:10.1016/j.ajogmf.2022.100575
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。